Short-term exposure to thapsigargin inhibits neointima formation in human saphenous vein

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 11, 1997, Pages 2500-2506

  George, S J ^a   Johnson, J L ^a   Angelini, G D ^a   Jeremy, J Y ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Calcium; Human saphenous vein; Metalloproteinases; Neointima; Smooth muscle cells

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); CALCIUM ION; GELATINASE A; GELATINASE B; LACTATE DEHYDROGENASE; METALLOPROTEINASE; THAPSIGARGIN; TISSUE INHIBITOR OF METALLOPROTEINASE;

ADULT; AGED; ARTERY INTIMA PROLIFERATION; ARTICLE; AUTORADIOGRAPHY; CALCIUM CELL LEVEL; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; MALE; PRIORITY JOURNAL; SAPHENOUS VEIN GRAFT; VASCULAR SMOOTH MUSCLE;

EID: 0031457545     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.11.2500     Document Type: Article

References (20)

1. Bryan AJ, Angelini GD. The biology of saphenous vein graft occlusion: etiology and strategies for prevention. Curr Opin Cardiol. 1994;9:641-649.
2. Nikol S, Huehns TY, Gonschior P, Hofling B. Myointimal hyperplasia. Crit Ischaemia. 1995;5:15-27.
3. Schwartz SM, deBlois D, O'Brien ERM. The intima: soil for atherosclerosis and restenosis. Circ Res. 1995;77:445-464.
4. Davies MG, Hagen P-O. Pathobiology of intimai hyperplasia: a review. Eur J Vasc Surg. 1995;9:7-18.
5. Newby AC, Fabunmi RP, George SJ, Southgate KM, Banning AP, Thurston VJ, Williams A. Neointimal fibrosis in vascular pathologies: role of growth factors and metalloproteinases in vascular smooth muscle proliferation. Exp Nephrol. 1995;3:108-113.
6. Dollery CM, McEwan JR, Henney AM, Matrix metalloproteinases and cardiovascular disease. Circ Res. 1995;77:863-868.
7. Bendeck MP, Zempo N, Clowes AW, Gelardy RE, Reidy MA. Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ Res. 1994;75:539-545.
8. Zempo N, Koyama N, Kenagy RD, Lea HJ, Clowes AW. Regulation of vascular smooth muscle cell migration and proliferation in vitro and injured rat arteries by a synthetic matrix metalloproteinase inhibitor. Arterioscler Thromb Vasc Biol. 1996;16:28-33.
9. Southgate KM, Davies M, Booth RFG, Newby AC. Involvement of extracellular-matrix-degrading metalloproteinases in rabbit aortic smooth muscle cell proliferation. Biochem J. 1992;288:93-99.
10. Moolenar WH, Defize LHK, De Laat SW. Calcium in the action of growth factors. Ciba FoundSymp. 1986;122:211-231.
11. 2+ pool content is linked to control of cell growth. Proc Natl Acad Sci U S A. 1993;90:4986-4990.
12. Lapidot SA, Phair RD. Platelet-derived growth factor causes sustained depletion of both inositol trisphosphate-sensitive and caffeine-sensitive intracellular calcium stores in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 1995;15:44-51.
13. 2+-channel blockers inhibit the action of recombinant platelet-derived growth factor in vascular smooth muscle cells. Proc Natl Acad Sci U S A. 1989;86:2388-2392.
14. Nomoto A, Hirosumi J, Sekiguchi C, Mutoh S, Yamaguchi I, Aoki H. Antiatherogenic activity of FR34235 (nilvadipine) a new potent calcium antagonist: effect on cuff-induced intimai thickening of rabbit carotid artery. Atherosclerosis. 1987;64:255-261.
15. Munro E, Patel M, Chan P, Betteridge L, Gallagher K, Schachter M, Wolfe J, Sever P. Effect of calcium channel blockers on the growth of human vascular smooth muscle cells derived from saphenous vein and vascular graft stenoses. J Cardiovasc pharmacol. 1994;23:779-784.
16. Whitworth HB, Roubin GS, Holman J, Meier B, Leimgruber PP, Douglas JS, King SB, Grunterzeig AR. Effect of nifedipine on recurrent stenosis after percutaneous transluminal coronary artery angioplasty. J Am Coll Cardiol. 1986;8:1271-1276.
17. O'Keefe JH Jr, Giorgi LV, Hartzler GO Good TH, Ligon RW, Webb DL, McCallister BD. Effects of diltiazem on complications and restenosis after coronary angioplasty. Am J Cardiol. 1991;67: 373-376.
18. Jackson CL, Schwartz SM. Pharmacology of smooth muscle cell replication. Hypertension. 1992;29:713-736.
19. Shukla N, Jeremy JY, Nicholl P, Krijgsman B, Stansby G, Hamilton G. Short-term exposure to low concentrations of thapsigargin inhibits replication of cultured human vascular smooth muscle cells. Br J Surg. 1997;84:325-330.
20. 2+ (+)-ATPase inhibitor, thapsigargin. Agents Actions. 1990;29:8-15.